Zeria Pharmaceutical Co., Ltd. (4559.T)

JPY 2454.0

(1.95%)

Total Debt Summary of Zeria Pharmaceutical Co., Ltd.

  • Zeria Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 47.58 Billion JPY , down -3.73% from previous year.
  • Zeria Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 44.4 Billion JPY , down -6.68% from previous quarter.
  • Zeria Pharmaceutical Co., Ltd. reported annual total debt of 49.43 Billion JPY in 2022, down -5.35% from previous year.
  • Zeria Pharmaceutical Co., Ltd. reported annual total debt of 52.22 Billion JPY in 2021, up 4.5% from previous year.
  • Zeria Pharmaceutical Co., Ltd. reported quarterly total debt of 47.58 Billion JPY for 2023 Q4, down -6.08% from previous quarter.
  • Zeria Pharmaceutical Co., Ltd. reported quarterly total debt of 50.66 Billion JPY for 2023 Q3, up 0.21% from previous quarter.

Annual Total Debt Chart of Zeria Pharmaceutical Co., Ltd. (2023 - 2005)

Historical Annual Total Debt of Zeria Pharmaceutical Co., Ltd. (2023 - 2005)

Year Total Debt Total Debt Growth
2023 47.58 Billion JPY -3.73%
2022 49.43 Billion JPY -5.35%
2021 52.22 Billion JPY 4.5%
2020 49.97 Billion JPY 42.08%
2019 35.17 Billion JPY -1.7%
2018 35.78 Billion JPY 6.49%
2017 33.6 Billion JPY -6.52%
2016 35.94 Billion JPY -17.73%
2015 43.69 Billion JPY 96.73%
2014 22.2 Billion JPY -16.07%
2013 26.46 Billion JPY -14.41%
2012 30.91 Billion JPY -9.5%
2011 34.16 Billion JPY -4.38%
2010 35.72 Billion JPY 11.38%
2009 32.07 Billion JPY 52.52%
2008 21.02 Billion JPY 31.79%
2007 15.95 Billion JPY -4.9%
2006 16.77 Billion JPY 21.21%
2005 13.84 Billion JPY 0.0%

Peer Total Debt Comparison of Zeria Pharmaceutical Co., Ltd.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY -181.723%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.018%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 88.64%
Shionogi & Co., Ltd. 11.62 Billion JPY -309.517%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -47235.503%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY -1556.891%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY -1135.998%
Eisai Co., Ltd. 206.74 Billion JPY 76.983%
Morishita Jintan Co., Ltd. 425 Million JPY -11096.684%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY -2165.996%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -12795.91%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY -274.044%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY -180.23%
Tsumura & Co. 79.69 Billion JPY 40.286%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY -2655.409%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -19402.421%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 76.484%
Fuji Pharma Co., Ltd. 28.94 Billion JPY -64.384%
KYORIN Holdings, Inc. 20.94 Billion JPY -127.184%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY -1149.302%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY -445.773%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -79209.847%
Modalis Therapeutics Corporation 412.5 Million JPY -11435.978%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY -401.696%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 42.591%
Cyfuse Biomedical K.K. 913 Million JPY -5112.038%
Toho Holdings Co., Ltd. 30.24 Billion JPY -57.34%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY -1584.285%